Literature DB >> 9889376

Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain.

J M de Gandarias1, E Echevarría, I Acebes, L C Abecia, O Casis, L Casis.   

Abstract

Fluoxetine is a selective serotonin reuptake inhibitor. Analysis of mu-opioid receptor immunostaining after chronic fluoxetine administration in rats revealed an increase in the density of cells expressing mu-opioid receptors in the caudatus-putamen, the dentate gyrus, the lateral septum and the frontal, parietal and piriform cortices. These data suggest that mu-opioid receptor expression in the rat forebrain is altered by in vivo chronic fluoxetine treatment. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9889376     DOI： 10.1016/s0006-8993(98)01256-6

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


  4 in total

1.  A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

Authors:  Erica M Richards; Daniel C Mathews; David A Luckenbaugh; Dawn F Ionescu; Rodrigo Machado-Vieira; Mark J Niciu; Wallace C Duncan; Neal M Nolan; Jose A Franco-Chaves; Thomas Hudzik; Carla Maciag; Shuang Li; Alan Cross; Mark A Smith; Carlos A Zarate
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

2.  Inducible expression of functional mu opioid receptors in murine dendritic cells.

Authors:  Zheng-Hong Li; Niansheng Chu; Li-Dong Shan; Shan Gong; Qi-Zhang Yin; Xing-Hong Jiang
Journal:  J Neuroimmune Pharmacol       Date:  2009-02-03       Impact factor: 4.147

3.  Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.

Authors:  Antonio Ortega-Alvaro; Ignacio Acebes; Gonzalo Saracíbar; Enrique Echevarría; Luis Casis; Juan Antonio Micó
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

4.  Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions.

Authors:  Shirley A Hesketh; Adrian K Brennan; David S Jessop; David P Finn
Journal:  Psychopharmacology (Berl)       Date:  2007-12-15       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.